| |
Latest 10 SEC filings (by transaction date) for ITOS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 7/24 | Gall Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 163,200 | |
Mar 8/24 | Mar 7/24 | Call Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 225,000 | |
Mar 8/24 | Mar 7/24 | McGrath Yvonne | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 153,600 | |
Mar 8/24 | Mar 7/24 | Detheux Michel | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 590,400 | |
Mar 7/24 | Mar 7/24 | DeSimone Jill | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 44,766 | |
Dec 7/23 | Dec 5/23 | McGrath Yvonne | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 31,000 | |
Dec 7/23 | Dec 5/23 | Call Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 44,000 | |
Dec 7/23 | Dec 5/23 | Gall Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 41,000 | |
Dec 7/23 | Dec 5/23 | Detheux Michel | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Dec 7/23 | Dec 5/23 | Lee David K | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 44,766 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ITOS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 7/24 | Gall Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 163,200 | |
Mar 8/24 | Mar 7/24 | Call Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 225,000 | |
Mar 8/24 | Mar 7/24 | McGrath Yvonne | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 153,600 | |
Mar 8/24 | Mar 7/24 | Detheux Michel | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 590,400 | |
Mar 7/24 | Mar 7/24 | DeSimone Jill | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 44,766 | |
Dec 7/23 | Dec 5/23 | McGrath Yvonne | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 31,000 | |
Dec 7/23 | Dec 5/23 | Call Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 44,000 | |
Dec 7/23 | Dec 5/23 | Gall Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 41,000 | |
Dec 7/23 | Dec 5/23 | Detheux Michel | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Dec 7/23 | Dec 5/23 | Lee David K | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 44,766 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |